Kager L, Liljeqvist L, Malmborg A S, Nord C E
Antimicrob Agents Chemother. 1981 Dec;20(6):736-40. doi: 10.1128/AAC.20.6.736.
Clindamycin was given intravenously to 15 patients undergoing colorectal surgery in an initial dose of 600 mg, given at induction of anesthesia followed by 6 doses of 600 mg at 8-h intervals. Series of serum samples and fecal specimens were taken for analysis of clindamycin concentrations. Tissue samples from the gut wall were taken at surgery. The highest serum concentrations observed occurred 30 min after administration of clindamycin and varied between 6.8 and 37.9 microgram/ml (mean, 14.8 +/- 2.0 [standard error] microgram/ml). The clindamycin concentrations in the tissue samples were between 1.8 and 13.0 microgram/g. Clindamycin concentration in the fecal samples varied between 2.1 and 460 microgram/g. Fecal samples were also collected during the investigation period for cultivation of aerobic and anaerobic bacteria. Among the aerobic bacteria, enterococci and streptococci decreased during the prophylaxis period. Anaerobic bacteria also decreased significantly during the same period. After the clindamycin administration period, enterococci, streptococci and anaerobic bacteria proliferated. No anaerobic strains resistant to clindamycin were isolated. Postoperative infections due to Streptococcus faecalis and different enterobacteria such as Escherichia coli, Enterobacter cloacae, Citrobacter freundii, and Klebsiella occurred in five patients.
对15例接受结直肠手术的患者静脉注射克林霉素,初始剂量为600mg,在麻醉诱导时给药,随后每8小时给药600mg,共给药6次。采集一系列血清样本和粪便标本用于分析克林霉素浓度。手术时采集肠壁组织样本。观察到的最高血清浓度在克林霉素给药后30分钟出现,范围在6.8至37.9微克/毫升之间(平均值为14.8±2.0[标准误]微克/毫升)。组织样本中的克林霉素浓度在1.8至13.0微克/克之间。粪便样本中的克林霉素浓度在2.1至460微克/克之间。在调查期间还采集粪便样本用于需氧菌和厌氧菌培养。在需氧菌中,肠球菌和链球菌在预防期间减少。厌氧菌在同一时期也显著减少。在克林霉素给药期后,肠球菌、链球菌和厌氧菌增殖。未分离出对克林霉素耐药的厌氧菌株。5例患者发生了由粪肠球菌和不同肠杆菌(如大肠杆菌、阴沟肠杆菌、弗氏柠檬酸杆菌和克雷伯菌)引起的术后感染。